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ABSTRACT 29 
We tested the hypothesis that dietary nitrate-rich beetroot juice (BR) supplementation could 30 
partially offset deteriorations in O2 transport and utilization, and exercise tolerance, after 31 
blood donation. Twenty-two healthy volunteers performed moderate-intensity and ramp 32 
incremental cycle exercise tests prior to and following the withdrawal of ~450 mL of whole 33 
blood. Before donation, all subjects consumed 7 x 70 mL of nitrate-depleted beetroot juice 34 
shots (PL) in the 48 h preceding the exercise tests. During the 48 h after blood donation, 35 
subjects consumed 7 shots of either BR (each containing 6.2 mmol nitrate; n=11) or PL 36 
(n=11) before repeating the exercise tests. [Hemoglobin] and hematocrit were reduced by ~8-37 
9% following blood donation (P<0.05), with no difference between the BR and PL groups. 38 
When compared with pre-donation, steady-state V̇O2 during moderate-intensity exercise was 39 
~4% lower post-donation in BR (P<0.05) but was unchanged in PL. The ramp test peak 40 
power decreased from pre-donation (PL: 341 ± 70 vs. BR: 331 ± 68 W) to post-donation (PL: 41 
324 ± 69 vs. BR: 322 ± 66 W) in both groups (P<0.05). However, the decrement in 42 
performance was significantly less in BR (2.7%) compared with PL (5.0%; P<0.05). Nitrate 43 
supplementation reduced the O2 cost of moderate-intensity exercise and attenuated the 44 
decline in ramp incremental exercise performance following blood donation. These results 45 
have implications for improving functional capacity following blood loss. 46 
 47 
New and Noteworthy: Dietary nitrate supplementation with beetroot juice lowered the O2 48 
cost of moderate-intensity exercise, better preserved muscle oxygenation and attenuated the 49 
decline in incremental exercise test performance following donation of 450 mL whole blood. 50 
These results have implications for improving functional capacity following blood loss. 51 
 52 
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INTRODUCTION 55 
The peak rate of pulmonary oxygen uptake (V̇O2peak) is an important determinant of exercise 56 
capacity and is influenced by the interaction of several central and peripheral factors (6, 53, 57 
64). V̇O2peak and exercise performance can be altered by manipulating the capability of the 58 
cardiovascular system to transport O2 to contracting skeletal muscles during exercise (5, 11, 59 
18, 51, 57, 67). For example, interventions involving the infusion of erythrocytes (18, 19) or 60 
the stimulation of erythropoiesis (57, 67) to enhance hemoglobin concentration ([Hb]), 61 
increase V̇O2peak during maximal exercise. Conversely, limiting O2 transport to working 62 
muscle by reducing [Hb] via whole blood withdrawal consistently results in a lowered 63 
V̇O2peak (11, 18, 47, 54). During sub-maximal exercise, however, Panebianco et al. (47) 64 
reported no change in V̇O2 at two and seven days post 450 mL blood donation, despite 65 
significant reductions in [Hb]. Compensatory adjustments in cardiovascular control, such as 66 
increases in heart rate (HR) and cardiac output (Q̇), offset the lower [Hb] and enable muscle 67 
O2 delivery to be maintained during low-intensity exercise after blood donation (19, 27, 51).  68 
 69 
The gaseous physiological signaling molecule, nitric oxide (NO), plays a key role in the 70 
regulation of vascular tone. NO can be synthesised via the oxidation of L-arginine in a 71 
reaction catalysed by the NO synthases (NOS; 32) or it can be produced via the reduction of 72 
nitrate (NO3
-
) to nitrite (NO2
-
) and subsequently NO (8). Recently, dietary NO3
-
 73 
supplementation has been employed to augment plasma [NO2
-
] and the potential for O2-74 
independent NO synthesis (4, 38, 65). This NO3
-
-NO2
-
-NO pathway may be particularly 75 
important when NOS activity is compromised (20, 42), O2 availability is limited (14, 25, 34, 76 
35) and pH is low (44). Limitations in systemic O2 transport can result in tissue hypoxia and 77 
greater metabolic perturbation (41, 60), which can contribute to reduced exercise tolerance 78 
(1), as is commonly observed at altitude (2) and in a number of disease states (35, 68). There 79 
is evidence to suggest that NO and NO2
-
 can combat an insufficient muscle O2 supply by 80 
increasing muscle blood flow via hypoxia-induced vasodilatation (13, 61). Therefore, it is 81 
possible that dietary NO3
-
 supplementation could ameliorate deteriorations in exercise 82 
performance when ‘normal’ O2 availability is reduced, during for example, high-intensity 83 
exercise, in hypobaric hypoxia or after blood donation.    84 
 85 
We and others have reported that, in healthy subjects, dietary NO3
-
 supplementation can 86 
significantly impact the physiological responses to exercise (4, 15, 38, 59). Specifically, a 87 
reduction in the O2 cost of moderate-intensity exercise has been reported after 88 
supplementation with both sodium NO3
-
 (38, 39, 40) and NO3
-
-rich beetroot juice (BR; 3, 4, 89 
15, 59, 69). In addition, a significantly increased time to task failure (TTF), indicating 90 
improved exercise tolerance, has been reported following BR ingestion when recreationally-91 
active, but not highly trained, subjects completed severe-intensity (3, 4, 37) and ramp 92 
incremental exercise (59). These alterations may be due to a NO2
-
 or NO-related reduction in 93 
the ATP cost of muscle contraction (3), greater mitochondrial efficiency (40), changes in 94 
muscle redox status (66), and/or enhanced muscle blood flow, particularly to type II fibres 95 
(21, 22). Such changes could be particularly advantageous after whole blood withdrawal 96 
when [Hb] is reduced and O2 transport is challenged (11, 18, 54). Indeed, BR 97 
supplementation has been shown to reduce muscle metabolic perturbation during exercise in 98 
normobaric hypoxia and to restore exercise tolerance and oxidative function to the values 99 
observed in normoxia (60, 61). In addition, it has been reported that, when the fraction of 100 
inspired O2 is lowered to 11-13%, BR supplementation can improve muscle oxygenation 101 
status (43), reduce V̇O2 during sub-maximal exercise (34, 46), and enhance TTF during 102 
incremental exercise (43). BR supplementation has also been reported to increase arterial O2 103 
saturation following dynamic apnea (i.e., breath-hold diving), which supports an O2 sparing 104 
effect of NO3
-
 ingestion (48). Collectively, these studies suggest that NO3
-
 ingestion may 105 
enhance the physiological response to exercise when O2 availability is limited, by sparing 106 
muscle O2 demand and/or better preserving muscle O2 supply. However, it is not known 107 
whether the reductions in O2 carrying capacity and exercise performance subsequent to the 108 
withdrawal of whole blood can be offset by BR supplementation. If so, this may have 109 
important implications for clinical conditions in which [Hb] is lowered, for example in 110 
anemia, following surgery or involuntary blood loss, or in athletes wishing to donate blood 111 
without compromising training.   112 
 113 
The purpose of the present study was to determine whether 48 h of BR supplementation 114 
following 450 mL of whole blood withdrawal alters the physiological responses to sub-115 
maximal and maximal intensity cycle exercise. It was hypothesized that BR supplementation 116 
would lower the O2 cost of moderate-intensity exercise, improve muscle oxygenation status, 117 
and attenuate the expected reduction in TTF during ramp incremental exercise following 118 
blood donation. 119 
 120 
METHODS 121 
Subjects 122 
Twenty-two recreationally active and pre-registered National Health Service (NHS) blood 123 
donors (males, n = 14; females, n = 8) volunteered to participate in this study, which was 124 
approved by the Institutional Research Ethics Committee and conformed to the ethical 125 
principles of the Declaration of Helsinki. None of the subjects were tobacco smokers or 126 
habitual users of dietary supplements. All subjects provided written informed consent prior to 127 
the commencement of the study, after the experimental procedures, associated risks and 128 
potential benefits of participation had been explained.  129 
 130 
Subjects were instructed to arrive at the laboratory in a rested and fully hydrated state, at least 131 
3 h postprandial, and to avoid strenuous exercise in the 24 h preceding each visit. In addition, 132 
subjects were asked to avoid alcohol consumption, chewing gum and antibacterial 133 
mouthwash throughout each supplementation period and to avoid caffeine intake in the 3 h 134 
preceding each laboratory visit. Each subject recorded habitual diet and exercise undertaken 135 
during the first supplementation period and were asked to replicate these habits during the 136 
second supplementation period. Prior to data collection, subjects were fully familiarized with 137 
the exercise testing procedures. This minimized any possible learning effects during the 138 
study. Exclusion criteria were the presence of known cardiovascular disease, hypertension 139 
and anemia, the use of antihypertensive medication and antibiotics, and having major surgery 140 
or giving blood within 6 months of the study commencing. 141 
 142 
Experimental Overview 143 
Subjects were asked to report to the laboratory on three separate occasions over a ten day 144 
period. The first visit included a 5 min bout of moderate-intensity cycle exercise at 80 W, 145 
followed by a ramp incremental test to task failure with no dietary supplementation. This 146 
served as the pre-intervention familiarization test. Hematocrit (Hct), [Hb], plasma [NO3
-
] and 147 
[NO2
-
], pulmonary V̇O2 dynamics, muscle oxygenation status, HR, blood lactate 148 
concentration ([lactate]), blood glucose concentration ([glucose]) and TTF during ramp 149 
incremental exercise were measured during the first visit and repeated during each visit to the 150 
laboratory. Prior to visit 2, subjects consumed 7 shots of NO3
-
-depleted beetroot juice (PL) 151 
over ~48 h. On the final day of supplementation, subjects completed the same moderate-152 
intensity exercise bout and ramp incremental test on a cycle ergometer as was performed at 153 
pre-intervention. Two days before the final visit to the lab, subjects attended a National 154 
Health Service (NHS) blood donation clinic. Each subject lay supine on a bed before ~450 155 
mL of whole blood was drawn from an antecubital vein over a 15 min period. The blood 156 
withdrawal was performed by the NHS as part of the national blood donation service. 157 
Following blood donation, each subject was randomly assigned, in a double-blind, placebo 158 
controlled fashion to consume 7 shots of either NO3
-
-rich beetroot juice (BR; n = 11; mean ± 159 
SD; females, n = 4:  age 23 ± 3 years, body mass 67 ± 4 kg, height 1.76 ± 0.05 m; males, n = 160 
7: age 26 ± 5 years, body mass 81 ± 12 kg, height 1.80 ± 0.10 m) or NO3
-
-depleted beetroot 161 
juice as a placebo (PL; n = 11; mean ± SD; females, n = 4: age 22 ± 3 years, body mass 77 ± 162 
11 kg, height 1.75 ± 0.10 m; males, n = 7: age 28 ± 7 years, body mass 77 ± 8 kg, height 1.79 163 
± 0.10 m) over the next ~48 h. Visit 3 occurred on the final day of supplementation with the 164 
exercise tests conducted 2 h following final supplement ingestion. All tests were performed at 165 
the same time of day (± 2 h) to minimise diurnal variation on the physiological variables 166 
under investigation.   167 
 168 
Exercise tests 169 
During the first visit to the laboratory subjects performed a short bout of low-intensity 170 
exercise at 80 W, followed by a ramp incremental exercise test to task failure on an 171 
electrically-braked cycle ergometer (Lode Excalibur Sport, Gronigen, The Netherlands) for 172 
determination of V̇O2peak and gas exchange threshold (GET). The protocol began with 3 min 173 
of ‘unloaded’ baseline cycling at 20 W, followed by 5 min at 80 W and 10 min of passive 174 
rest. Subsequently, 3 min of baseline cycling at 20 W was performed and then the power 175 
output was increased linearly by 30 W
.
min
-1
 until the subject was unable to continue. The 176 
subjects cycled at a self selected cadence (~80 rpm), and this cadence, along with saddle and 177 
handle bar configuration, was recorded and replicated for subsequent tests. Pulmonary gas 178 
exchange was measured breath-by-breath and averaged into 10-s bins. V̇O2peak was taken as 179 
the highest 30-s mean value attained during the test. The GET was determined as described 180 
previously (59). The work rate that would require 80% of the GET (moderate-intensity 181 
exercise) was calculated, taking into account the mean response time for V̇O2 during ramp 182 
exercise (59).  183 
 184 
Subjects returned to the laboratory on two further occasions. The second visit was preceded 185 
by PL supplementation (n = 22) and the third visit, ~48 h post blood donation, was preceded 186 
by 2 days of either BR (n = 11) or PL (n = 11) supplementation. The final visit was 187 
conducted 48 h post donation to allow restoration of total blood volume (23) and to minimize 188 
the risk of a syncopal episode occurring during maximal exercise. On each of these two 189 
laboratory visits, subjects completed a single 5-min bout of moderate-intensity exercise (at 80 190 
% of the GET) and a ramp incremental test to task failure, separated by 10 min of passive 191 
rest. The incremental test was terminated when cadence fell more than 10 rpm below the 192 
chosen cadence, despite strong verbal encouragement. TTF was recorded to the nearest 193 
second and the power output achieved at the point of test termination was recorded as the 194 
peak power output (PPO). Feedback on performance was only provided once all 195 
experimentation for the entire study had been completed. 196 
 197 
Measurements 198 
During each visit to the laboratory, a venous blood sample (~4 mL) was drawn from an 199 
antecubital vein into lithium-heparin tubes (Vacutainer, Becton-Dickinson, NJ, USA) and 200 
centrifuged for 10 min at 3000 g and 4˚C, within 2 min of collection. Subsequently, the 201 
plasma was extracted and frozen at -80˚C for later determination of [NO3
-
] and [NO2
-
] using a 202 
modified chemiluminescence technique (7) as previously described (69). Blood samples from 203 
a pre-warmed fingertip were collected into four 30 μl heparinized microhematocrit tubes 204 
(Hawksley and Sons Ltd, Lancing, Sussex, England) which underwent microcentrifugation 205 
for 1 min for the determination of Hct (1560 Micro-haematocrit reader, Hawksley and Sons 206 
Ltd, Lancing, Sussex, England). In addition, blood from the same fingertip was collected into 207 
four microcuvettes for determination of [Hb] (HemoCue AB, Ängelholm, Sweden).  208 
 209 
Pulmonary gas exchange and ventilation were measured breath-by-breath throughout all 210 
exercise tests. Subjects wore a nose clip and breathed through a mouthpiece and impeller 211 
turbine assembly (Jaeger Triple V). The inspired and expired gas volume and gas 212 
concentration signals were sampled continuously at 100 Hz, with the latter using 213 
paramagnetic (O2) and infrared (carbon dioxide; CO2) analyzers (Oxycon Pro, Jaeger, 214 
Hoechberg, Germany) via a capillary line connected to the mouthpiece. These analyzers were 215 
calibrated before each test with gases of known concentration, and the turbine volume 216 
transducer was calibrated using a 3-litre syringe (Hans Rudolph, Kansas City, MO, USA). 217 
The volume and concentration signals were time-aligned by accounting for the delay in 218 
capillary gas transit and analyzer rise time relative to the volume signal. Pulmonary O2 219 
uptake (V̇O2), CO2 output (V̇CO2), minute ventilation (V̇E) and respiratory exchange ratio 220 
(RER) were calculated and displayed breath-by-breath. HR was measured at rest and during 221 
all cycle tests using short-range radiotelemetry (Polar S610, Polar Electro Oy, Kempele, 222 
Finland). A fingertip blood sample was collected into a capillary tube over the 20 s preceding 223 
the step transition in work rate to moderate-intensity exercise and the incremental test. 224 
Capillary samples were also collected during the final 20 s of the moderate-intensity exercise 225 
bout and following exhaustion in the ramp test. These samples were analyzed within 60 s of 226 
collection to determine blood [lactate] (YSI 2300, Yellow Springs Instruments, Yellow 227 
Springs, OH, USA). 228 
 229 
The oxygenation status of the m. vastus lateralis of the right leg was monitored using near-230 
infrared spectroscopy (NIRS; model NIRO 300, Hamamatsu Photonics KK, Hiugashi-ku, 231 
Japan). Four different wavelength laser diodes provided the light source (776, 826, 845 and 232 
905 nm) and a photomultiplier tube in the spectrometer was used to detect the light returning 233 
from the tissue. The intensity of incident and transmitted light was recorded continuously 234 
throughout exercise at 2 Hz and used to estimate the change in concentration from baseline 235 
for oxygenated, deoxygenated, and total tissue Hb and myoglobin. The NIRS data therefore 236 
represent a relative change based on the optical density measured in the first data point 237 
collected. The deoxyhemoglobin concentration ([HHb]) was assumed to represent the balance 238 
between local O2 supply and utilization and therefore to provide an estimate of changes in O2 239 
extraction within the field of interrogation (28, 36). Prior to the cycling exercise, the right leg 240 
was cleaned and shaved around the belly of the muscle, the probes were placed in the holder 241 
and attached to the skin with an adhesive 20 cm above the fibular head. An elastic bandage 242 
was wrapped around the subject’s leg to secure the holder and wires in place and to minimize 243 
the possibility of extraneous light influencing the signal. Pen marks were made around the 244 
probe holder to allow for precise reproduction of the position of the probe in subsequent tests. 245 
The probe gain was set at rest with the subject in a seated position and the leg extended at 246 
down stroke on the cycle ergometer. NIRS data were collected continuously throughout the 247 
moderate-intensity and incremental exercise tests.  248 
 249 
Supplementation 250 
After completion of the familiarization test, subjects consumed 7 shots of NO3
-
-depleted 251 
beetroot juice (PL; beetroot juice containing ~0.04 mmol NO3
-
 per 70 mL; Beet It Sport 252 
Stamina Shot, James White Drinks, Ltd., Ipswich, UK) over ~48 h before completing the pre-253 
donation control trial (PL-Pre and BR-Pre for the PL and BR groups, respectively). This was 254 
done in order to control for the antioxidants and polyphenols that exist in both the NO3
-
-rich 255 
and NO3
-
-depleted beverages. The PL was created by passing NO3
-
-rich BR through a 256 
Purolite A520E ion-exchange resin which selectively removes NO3
-
 (37). After blood 257 
donation, subjects were randomly assigned, in a double-blind, placebo-controlled fashion, to 258 
consume 7 shots of either NO3
-
-rich (BR; beetroot juice containing ~6.2 mmol NO3
-
 per 70 259 
mL; Beet It Sport Stamina Shot, James White Drinks, Ltd., Ipswich, UK; n =11) or NO3
-
-260 
depleted beetroot juice (PL; beetroot juice containing ~0.04 mmol NO3
- 
per 70 mL; Beet It, 261 
James White Drinks, Ltd., Ipswich, UK;n =11) over ~48 h (PL-Post and BR-Post for the PL 262 
and BR groups, respectively). During both supplementation periods subjects were instructed 263 
to consume 2 x 70 mL of the beverage in the evening (~7 p.m.) two days prior to testing, and 264 
1 x 70 mL in the morning (~10 a.m.) and 1 x 70 mL in the evening (~7 p.m.) one day prior to 265 
testing. On each experimental day, subjects consumed a further 2 x 70 mL, 2 h prior to testing 266 
and 1 x 70 mL on arrival at the laboratory. The supplementation periods were separated by a 267 
mean of 8 days (BR: 7 ± 5 days, PL: 9 ± 5 days).  268 
 269 
Data Analyses 270 
The breath-by-breath V̇O2 data collected during the exercise tests were initially examined to 271 
exclude errant breaths caused by, for example, coughing, swallowing and sighing, and those 272 
values lying more than four standard deviations (SDs) from the local mean were removed. 273 
V̇O2baseline was defined as the mean V̇O2 measured over the last 60 s of baseline cycling and 274 
end-exercise V̇O2 was defined as the mean V̇O2 measured over the last 30 s of exercise. The 275 
baseline and end-exercise V̇CO2, RER, V̇E and HR values were calculated in the same 276 
manner.  277 
 278 
To provide information on muscle oxygenation, the changes in [HHb] and the tissue 279 
oxygenation index (TOI; calculated as the fraction of oxygenated [Hb] compared to total 280 
[Hb]) during moderate-intensity exercise were assessed at baseline (60 s preceding the 281 
transition to moderate-intensity exercise), in 10 s time bins surrounding 60 s, 120 s, 240 s, 282 
and at end-exercise (mean response over the final 30 s of exercise). During ramp incremental 283 
exercise, the changes in [HHb] and TOI were assessed at baseline, in 10 s time bins 284 
surrounding 120 s, 240 s, 360 s and at task failure. 285 
 286 
Blood lactate accumulation (Δ blood [lactate]) was calculated as the difference between 287 
blood [lactate] at end-exercise and blood [lactate] at baseline. Similarly, the change in blood 288 
glucose concentration (Δ blood [glucose]) was calculated as the difference between blood 289 
[glucose] at end-exercise and blood [glucose] at baseline. 290 
 291 
Statistical Analyses  292 
Differences in Hct, [Hb], plasma [NO3
-
] and [NO2
-
], pulmonary V̇O2 dynamics, HR, blood 293 
[lactate], NIRS-derived variables and TTF were assessed using a mixed model ANOVA. 294 
Significant main and interaction effects were further explored using Fisher’s LSD. 295 
Independent t-tests were used to assess the relative change between the BR and PL treatment 296 
groups. Pearson’s product moment correlation coefficient was used to explore relationships 297 
between changes in [Hb] and Hct and changes in TTF. Statistical analyses were performed 298 
using SPSS version 19.0 (Chicago, IL, USA). Data are presented as mean ± SD, unless 299 
otherwise stated. Statistical significance was accepted at P<0.05.  300 
 301 
RESULTS 302 
Subjects’ self-reported adherence to the supplementation regimen prior to and post blood 303 
donation was 100%. All subjects reported that their physical activity and dietary patterns 304 
were similar throughout each of the supplementation periods. The ingestion of BR and PL 305 
supplements were well tolerated and no negative side effects were reported. Subjects did, 306 
however, report beeturia (red-stained urine). 307 
 308 
[Hb] and Hct 309 
The group mean [Hb] and Hct data prior to and following blood donation and BR or PL 310 
ingestion are displayed in Table 1. There was a significant main effect by time for both [Hb] 311 
and Hct (P<0.01) but no main effect by group and no interaction effect (P>0.05). Prior to 312 
donation, [Hb] and Hct were not different between the BR and PL treatment groups. [Hb] and 313 
Hct were both significantly reduced from pre to post donation (P<0.05), with no differences 314 
between PL and BR groups (P>0.05). 315 
  316 
Plasma [NO3
-
] and [NO2
-
] 317 
The group mean plasma [NO3
-
] and [NO2
-
] pre and post blood donation in the BR and PL 318 
groups are shown in Table 1. There was a significant main effect by time and group and an 319 
interaction effect on plasma [NO3
-
] and [NO2
-
] (P<0.01). Prior to blood donation, neither 320 
plasma [NO3
-
] nor [NO2
-
] were different between groups (P>0.05). Following blood 321 
donation, there was a substantial increase in plasma [NO3
-
] and [NO2
-
] in the BR group 322 
(P<0.05). A small (~11%) rise in plasma [NO3
-
] (P<0.05) was also observed in the PL group 323 
but there was no change in plasma [NO2
-
] (P>0.05).  324 
 325 
V̇O2 response to moderate-intensity and incremental exercise 326 
Moderate-intensity exercise  327 
The pulmonary gas exchange and ventilatory responses to moderate-intensity exercise pre 328 
and post blood donation in PL and BR groups are reported in Table 2 and the group mean 329 
V̇O2 response profiles in BR and PL groups pre and post blood donation are shown in Figure 330 
1. There was a significant main effect by time (P<0.01) but no main effect by condition and 331 
no interaction effect (P>0.05) for the V̇O2 measured during the baseline cycling period and at 332 
end-exercise. Prior to donation, there were no differences in baseline or end-exercise V̇O2 333 
between BR and PL groups (P>0.05). Follow-up tests revealed that both baseline V̇O2 334 
(P<0.01) and end-exercise V̇O2 (P<0.05) were reduced in the BR group post-donation 335 
compared with pre-donation.  336 
 337 
The V̇CO2, V̇E, RER, blood [lactate] and blood [glucose] data during moderate-intensity 338 
exercise are reported in Table 2. Prior to donation, there were no differences in these 339 
variables at baseline or at end-exercise between the BR and PL groups (P>0.05) and there 340 
were no significant main effects by condition or time and no interaction effects (P>0.05).  341 
 342 
Ramp incremental exercise 343 
The effects of blood donation and BR and PL supplementation on the ramp incremental test 344 
parameters are reported in Table 3 and illustrated in Figures 2 and 3.  345 
 346 
There was a significant main effect by time on V̇O2peak (P<0.05), but no main effect by 347 
condition or an interaction effect (P>0.05). There were no differences between the groups at 348 
baseline (P>0.05). Follow-up tests indicated that, from pre to post donation, there was a 349 
significant reduction (0.19 L·min
-1
; ~5%) in V̇O2peak in the PL group (P<0.05) but not in the 350 
BR group (0.12 L·min
-1
; ~3%; P>0.05). There was a significant main effect by time and an 351 
interaction effect (P<0.05) but no main effect by condition (P>0.05) for PPO and TTF. Post 352 
hoc tests revealed a significant reduction in PPO and TTF in both PL and BR groups from pre 353 
to post donation (P<0.01). There were no differences in PPO or TTF between the groups 354 
prior to blood donation (P>0.05). However, the reduction in PPO and TTF following blood 355 
donation was more pronounced in PL compared with BR (5% vs. 3%; P<0.05). The change 356 
in [Hb] and Hct from pre to post donation was correlated with the change in TTF during ramp 357 
incremental exercise in PL (r = 0.58; P=0.06, and r = 0.70; P<0.05, respectively) but not BR 358 
(r = -0.10; P>0.05 and r = -0.41; P>0.05, respectively).  359 
 360 
There was a significant interaction effect, but no main effects by time or group, for peak 361 
V̇CO2. Specifically, peak V̇CO2 was reduced in the PL group (P<0.05), but was unaffected in 362 
the BR group (P>0.05). There was no main effect by time or condition nor an interaction 363 
effect for peak V̇E (P>0.05). There was a significant main effect by time and an interaction 364 
effect for peak RER (P<0.05). Despite no difference at baseline, post hoc tests revealed an 365 
increase in peak RER in the BR group from pre to post donation (P<0.01).  366 
 367 
NIRS measurements 368 
Moderate-intensity exercise 369 
There were no differences for total Hb (THb) between or within conditions during 370 
the moderate-intensity exercise bout. The [HHb] and TOI values measured during moderate-371 
intensity exercise are reported in Table 4. There were no main effects by condition or time 372 
and no interaction effect for baseline [HHb] (P>0.05). There was a significant main effect by 373 
time for [HHb] from pre to post donation at 60 s, 120 s, 240 s and end-exercise (P<0.05), but 374 
no main effect by condition or an interaction effect at any time point (P>0.05). Post hoc tests 375 
revealed a trend toward an increase in [HHb] in the PL group, but not the BR group, from pre 376 
to post donation at 120 s and 240 s of moderate exercise (P<0.10). There were no main 377 
effects by time or interaction effects for TOI at 60 s, 120 s, 240 s and end-exercise (P>0.05). 378 
However, there was a trend toward a main effect by condition for all time points (P<0.10). 379 
Follow-up tests revealed that blood donation resulted in reductions in TOI in the PL group at 380 
60 s, 120 s and 240 s during moderate exercise, respectively (P<0.05; Table 4).  381 
 382 
Ramp incremental exercise 383 
There were no differences for THb between or within conditions during ramp incremental 384 
exercise. The [HHb] and TOI values measured during ramp incremental exercise are reported 385 
in Table 4 and the [HHb] profile is shown in Figure 4. There was a significant main effect by 386 
time (P<0.05) but no main effect by condition or an interaction effect (P>0.05) for [HHb] at 387 
120 s and 240 s during ramp incremental exercise. Post hoc tests showed that [HHb] 388 
increased from pre to post donation at 240 s in PL (P<0.05) but not BR (P>0.05; Table 4). 389 
There was a significant main effect by time (P<0.05) and a trend for an interaction effect for 390 
[HHb] at 360 s (P<0.10) and at end-exercise (P<0.05) during the incremental exercise test. 391 
Post hoc tests revealed that [HHb] increased significantly from pre to post donation in the PL 392 
group at both 360 s and end-exercise (P<0.05; Table 4). The change in [HHb] from pre to 393 
post donation was higher in PL versus BR at end-exercise (P<0.05) and tended to be higher at 394 
360 s (P<0.10).  395 
 396 
DISCUSSION 397 
The principal original findings in this study, consistent with our hypotheses, were that NO3
-
-398 
rich beetroot juice ingestion lowered the O2 cost of moderate-intensity exercise, better 399 
preserved muscle oxygenation during moderate and ramp incremental exercise and attenuated 400 
the reduction in ramp incremental exercise test performance and V̇O2peak following blood 401 
donation. These results indicate that dietary NO3
-
 supplementation can ameliorate decrements 402 
in exercise performance in a situation (i.e. reduction in blood O2-carrying capacity) which 403 
would be expected to compromise physiological function during exercise. 404 
 405 
Effects of blood donation on [Hb] and Hct 406 
The standard NHS blood bank donation (~450mL) reduced [Hb] and Hct by a similar 407 
magnitude in the PL and BR groups. These results concur with previous studies that have 408 
investigated the influence of whole blood withdrawal on [Hb]. For example, Gordon et al. 409 
(27) and Mora-Rodriguez et al. (45) reported ~8% and ~7% reductions in [Hb], 24 and 48 h 410 
post blood donation, respectively. The ~8% reduction in Hct in the present study is also 411 
similar to the values reported by Burnley et al. (11) and Gordon et al. (27) who reported a ~7-412 
8% decrease in Hct one day after 450 mL blood donation. The reduction in blood O2 carrying 413 
capacity, secondary to the lower [Hb] and Hct, can result in a reduction in muscle O2 delivery 414 
and muscle O2 diffusing capacity during maximal exercise, with significant implications for 415 
exercise performance (5, 11, 18, 47, 54).  416 
 417 
Effects of nitrate supplementation on plasma [NO3
-
] and [NO2
-
] 418 
The ingestion of NO3
-
-rich BR significantly elevated plasma [NO3
-
] and [NO2
-
] when 419 
compared with baseline values. These findings are in agreement with earlier studies which 420 
also examined the influence of BR supplementation in young, healthy subjects (4, 34, 69). 421 
A small but significant rise in plasma [NO3
-
] was also noted in the PL group post 422 
donation. This may be explained by a slight hemoconcentration or an upregulation in NOS 423 
activity consequent to the reduction in whole body iron concentration after donating blood 424 
(62). Plasma [NO2
-
] rose by ~800% in the BR group from pre to post donation, suggesting 425 
appreciably enhanced NO bioavailability. Numerous other studies have also reported 426 
increases in plasma [NO2
-
] after BR supplementation, but the percentage increases 427 
attained were approximately half of those reported in this study (56, 69). This finding is 428 
likely a result of the higher dose of NO3
-
 ingested (~43 mmol over 48 h) when compared 429 
with previous short-term BR supplementation studies. Interestingly, unlike in some earlier 430 
studies (4, 38, 59, 69), BR supplementation did not reduce resting blood pressure (BP) 431 
despite the elevated plasma [NO2
-
] (mean arterial pressure, pre- vs. post-donation: 81 ± 7 432 
vs. 80 ± 7 mmHg). Similar BP values pre- vs. post-donation in the PL group indicates that 433 
total blood volume was restored 48 h following blood donation. The lack of effect of BR 434 
on BP in the present study may be related to the relatively low baseline BP values of the 435 
study participants (115/64 mmHg) and the relatively large number of female participants. 436 
It has been reported that females are less sensitive than males to the influence of NO3
-
 437 
supplementation on BP and that the extent of BP reduction with NO3
-
 supplementation is 438 
correlated with the baseline BP (33).      439 
 440 
Effects of blood donation and nitrate supplementation on the physiological responses to 441 
moderate-intensity exercise 442 
The V̇O2 during both the unloaded baseline period and in the steady state of moderate-443 
intensity exercise was significantly reduced (by ~4%) in the BR group, but not the PL group, 444 
after blood donation. A similar reduction in the O2 cost of moderate-intensity exercise has 445 
been reported by Bailey et al. (4) after six days of non-concentrated NO3
-
-rich BR ingestion 446 
and by Larsen et al. (38) after three days of NaNO3 supplementation. The present findings are 447 
consistent with those of Kelly et al. (34) who observed that, in hypoxia, BR supplementation 448 
resulted in a decrease in both baseline and steady-state V̇O2 when compared with placebo. It 449 
has also been reported that acute (46) and 6 days (43) BR ingestion resulted in significant 450 
reductions in V̇O2 during submaximal cycling exercise in hypoxia (15% and 11% O2, 451 
respectively). Acute BR supplementation has also been reported to better preserve arterial O2 452 
saturation following dynamic apnea (48).   453 
 454 
The lowering of the O2 cost of submaximal exercise after NO3
-
 supplementation may be due 455 
to a number of mechanisms, including a reduction in the ATP cost of muscle force production 456 
(4) and/or an improvement in mitochondrial efficiency (40) and/or changes in redox 457 
signalling (66). In addition to changes in muscle contractile or metabolic efficiency, muscle 458 
O2 delivery or its intramuscular distribution may be altered following NO3
-
 supplementation 459 
(21, 22). Exercise, particularly in hypoxia or under conditions that may limit O2 carrying 460 
capacity, such as blood donation, acts as a potent stimulus for vasodilatation and delivery of 461 
O2 to working muscle (12, 13). Both NO and O2 compete for the binding site at cytochrome-c 462 
oxidase (COX) in the mitochondrial electron transport chain (9). An elevation in NO 463 
availability via NO3
-
 supplementation, perhaps especially in conditions limiting O2 delivery, 464 
increases the likelihood of NO binding to COX and therefore inhibiting O2 consumption at 465 
the mitochondrion (10). As a result, NO may modify the intramuscular distribution of O2 and 466 
improve the oxygenation status of muscle fibres that are situated further away from the 467 
capillaries (29, 55, 63). Compared to placebo, BR supplementation has been reported to 468 
enable a greater maximal rate of mitochondrial ATP resynthesis (Qmax) and result in faster 469 
muscle phosphocreatine recovery kinetics following exercise in hypoxia (60, 61), indicating 470 
improved muscle O2 availability at least in the immediate post-exercise period (61).    471 
 472 
In the present study, TOI was significantly reduced and [HHb] tended to be higher during 473 
moderate-intensity exercise post- compared to pre-donation in the PL group, suggesting that 474 
muscle O2 availability was lower and a greater muscle fractional O2 extraction was necessary 475 
to achieve the required V̇O2 (24, 36). These changes were attenuated in the BR group, 476 
consistent with our hypothesis that BR supplementation would better preserve muscle 477 
oxygenation during moderate-intensity exercise when compared with PL. These results are 478 
consistent with Masschelein et al. (43) who reported that BR resulted in a greater muscle TOI 479 
and lower [HHb] during submaximal exercise in normobaric hypoxia. Collectively, these 480 
studies indicate that under conditions which may impair blood O2 carrying capacity, such as 481 
following blood donation (present study) or in normobaric hypoxia (43), BR ingestion 482 
promotes a better matching between muscle O2 delivery and O2 demand, i.e. less O2 extraction 483 
is required for the same moderate-intensity work rate, perhaps due to the lower exercise V̇O2 484 
(34) or to preferential alterations in muscle perfusion (21, 22, 61). An increased ratio of O2 485 
delivery to O2 consumption at a given work rate would be expected to retard the rate of 486 
fatigue development and to improve exercise performance.   487 
 488 
Effects of blood donation and nitrate supplementation on the physiological responses to 489 
incremental exercise 490 
As expected, blood donation and the associated reduction in O2 carrying capacity resulted in a 491 
significant reduction in PPO and TTF during ramp incremental exercise. Panebianco et al. 492 
(47) also reported a significant reduction in PPO during incremental exercise, 2 days post 493 
blood donation. An important original finding in the present study was that ingestion of BR in 494 
the 48 hours post blood donation partly negated the decrement in performance when 495 
compared with PL. Specifically, the reduction in PPO and TTF following blood donation was 496 
significantly more pronounced in the PL group compared with BR. Interestingly, the 497 
reduction in TTF in the PL group was quite well correlated with the reduction in [Hb] (r = 498 
0.58, P=0.06) and Hct (r = 0.70, P<0.05) following blood donation, whereas in the BR group, 499 
the correlations were weaker and non-significant ([Hb]: r = -0.10; Hct: r = -0.41; both 500 
P>0.05), implying that BR supplementation compensated for the lower [Hb] and Hct. These 501 
findings are consistent with those of Masschelein et al. (43) who reported that, compared to 502 
PL, BR ingestion significantly attenuated the reduction in TTF when incremental exercise 503 
was performed in hypoxia.  504 
 505 
V̇O2peak was reduced by 5% from pre to 48 h post donation in the PL group. Similarly, 506 
Burnley et al. (11) reported a 4% decrease in V̇O2peak during severe-intensity exercise 24 h 507 
following blood donation. This reduction was proportional to the reduced [Hb] and thus the 508 
ability to deliver O2 to the working skeletal muscle during maximal exercise. In the present 509 
study, the reduced V̇O2peak in the PL group following blood donation occurred in conjunction 510 
with an increased muscle [HHb], which may be interpreted as an increase in muscle 511 
fractional O2 extraction in an (ultimately unsuccessful) attempt to offset the effects of a 512 
reduced [Hb] and lower muscle O2 delivery (51, 54). In contrast, V̇O2peak and [HHb] during 513 
the incremental test were not significantly altered by blood donation in the BR group. These 514 
results may indicate that the O2 sparing effect of BR ingestion (Figure 2B), coupled perhaps 515 
with altered perfusion distribution (21, 22, 61), enabled muscle oxygenation to be better 516 
preserved during incremental exercise, such that an increased muscle fractional O2 extraction 517 
was not mandated to achieve a given V̇O2peak. Ferguson et al. (21, 22) have reported that, in 518 
rats, BR supplementation can enhance vascular conductance and blood flow to working 519 
muscle and elevate the microvascular partial pressure of O2 (PO2mv), particularly in type II 520 
fibres. If similar effects occur in humans, this may enhance the blood-myocyte O2 exchange 521 
gradient during higher intensity exercise, better preserving muscle oxygenation status, 522 
homeostasis and performance. It is also possible that a portion of the preserved ramp 523 
incremental test performance following blood donation with BR compared to PL may be 524 
attributable to effects of NO3
- 
on muscle contractile function (50), perhaps particularly in type 525 
II fibers (31).   526 
 527 
The mechanistic bases for the positive effects of BR ingestion on vascular and metabolic 528 
function in this and other situations warrants further investigation. In particular, while it is 529 
widely believed that the effects may be attributed to greater NO bioavailability or bioactivity, 530 
it is presently unclear precisely how this NO pool is stored and transported. NO is a highly 531 
reactive molecule with a short-half life in vivo and its rapid reaction with, for example, O2 or 532 
heme proteins (30) suggests that the free transport of NO may be limited in plasma and 533 
within cells. It has been proposed that NO2
-
 itself represents a principal means of ‘NO’ 534 
storage and transport, with the one electron reduction of NO2
-
 to NO in blood and other 535 
tissues being facilitated, amongst many other factors including xanthine oxidoreductase, by 536 
deoxyhemoglobin and deoxymyoglobin, which will naturally be present in greater abundance 537 
in contracting skeletal muscle (16, 42). However, BR ingestion likely also increases the 538 
production and storage of other reactive nitrogen species. In particular, low molecular weight 539 
thiol groups may react with nitrogen oxides to yield s-nitrosothiol species (SNOs) which can 540 
be transported in the blood as s-nitrosohemoglobin (HbSNO) (17). It has recently been 541 
reported that the reduction in blood pressure following NO3
-
 or NO2
-
 ingestion in a rat model 542 
of hypertension was more closely related to plasma [s-nitrosothiol] than to plasma [NO2
-
] 543 
(49) and that s-nitrosothiol bioactivity derived through βCys93 may be essential for hypoxic 544 
vasodilation by erythrocytes (70). In contrast, in humans, Gladwin et al. (26) reported a 545 
significant arterial-venous NO2
-
 gradient during forearm exercise and concluded that SNOs 546 
and HbSNO do not play a significant role in the regulation of vascular tone. The role of 547 
SNOs and HbSNO in the physiological effects of nitrate ingestion in humans remains to be 548 
clarified. Equally, the precise mechanisms by which an elevation of tissue [NO2
-
] following 549 
NO3
-
 ingestion influences metabolic and vascular control at rest and during exercise remains 550 
unclear. While it is possible that NO2
-
 itself is bioactive (58), unresolved questions include 551 
the triggers and time course for the possible reduction of NO2
-
 to NO, and the nature of both 552 
NO transport to, and storage within, biological targets. Resolution of these issues will likely 553 
require synthesis of experimental data deriving from ‘competing’ hypotheses.     554 
   555 
Perspectives 556 
This study has shown for the first time that despite a significant reduction in [Hb] post blood 557 
withdrawal, BR supplementation lowered the O2 cost of moderate-intensity exercise, better 558 
preserved muscle oxygenation during moderate-intensity and ramp incremental exercise, and 559 
attenuated the reduction in V̇O2peak and incremental exercise test performance. These results 560 
may have significant implications for athletes who wish to give blood without significant 561 
detriment to training, individuals with clinical conditions which reduce blood O2 carrying 562 
capacity, such as anemia, and in conditions resulting in acute blood loss such as surgery or 563 
military combat. In this context, it is of interest that transfusion of stored blood may impair 564 
vasodilatory capacity, an effect that might be linked to the loss of NO bioavailability that 565 
occurs during blood storage (17, 52). Treating banked blood to better maintain NO stores 566 
might lead to improved functional outcomes following transfusion. In conclusion, BR 567 
supplementation attenuates the decline in functional capacity arising from blood donation.   568 
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FIGURE LEGENDS 849 
Figure 1: Pulmonary oxygen uptake (V̇O2) response following BR and PL supplementation 850 
prior to and following blood donation during a step increment to a moderate-intensity work 851 
rate. Responses prior to blood donation are shown as solid, filled circles, while responses post 852 
blood donation are shown as open, unfilled circles. The dotted vertical line represents the 853 
abrupt imposition of the moderate work rate from a baseline of ‘unloaded’ cycling. A: Group 854 
mean V̇O2 response to moderate-intensity exercise following PL ingestion. B: Group mean 855 
V̇O2 response to moderate-intensity exercise following BR ingestion. C: Steady state V̇O2 856 
following PL and BR supplementation relative to pre blood donation baseline. The O2 cost of 857 
moderate-intensity exercise was reduced following BR supplementation and blood donation 858 
compared with pre donation values, *P<0.05.   859 
 860 
Figure 2: Group mean pulmonary V̇O2 response to incremental exercise prior to blood 861 
donation and following BR and PL supplementation after blood donation. Responses prior to 862 
blood donation are shown as solid, filled circles, while responses post blood donation are 863 
shown as open, unfilled circles. The dotted vertical line represents the onset of the ramp 864 
incremental test from a baseline of ‘unloaded’ cycling. The V̇O2peak was reduced in the PL 865 
group (*= P<0.05), but not the BR group, after blood donation. TTF was reduced in both 866 
groups post donation (
#
 = P<0.05), however, the reduction in TTF was greater in the PL 867 
group when compared with the BR group (
$
 = P<0.05). 868 
 869 
Figure 3. Group mean time to task failure (TTF) in the ramp incremental test prior to and 870 
post blood donation, following BR and PL supplementation. Responses prior to blood 871 
donation are shown as solid, filled bars, while responses post donation are shown as open, 872 
unfilled bars. The TTF was reduced in both groups post donation (*= P<0.05); however, the 873 
reduction in TTF was greater in the PL group when compared with the BR group (
#
=P<0.05). 874 
 875 
Figure 4. Group mean changes in deoxyhaemoglobin ([HHb]) prior to and post blood 876 
donation, following BR and PL ingestion. Responses prior to blood donation are shown as 877 
solid, filled circles, while responses post blood donation are shown as open, unfilled circles. 878 
The dotted vertical line represents the onset of the ramp incremental test from a baseline of 879 
‘unloaded’ cycling. [HHb] increased significantly from pre to post donation in the PL group 880 
at 360 s and end-exercise (*=P<0.05). [HHb] was not altered from pre to post donation in the 881 
BR group. TTF was reduced in both groups post donation (
#
 = P<0.05), however, the 882 
reduction in TTF was greater in the PL group when compared with the BR group (
$
 = 883 
P<0.05). 884 
 885 
 886 
Table 1: Blood pressure, resting heart rate, plasma nitrate and nitrite concentrations, 
hemoglobin concentration and hematocrit prior to and following blood donation in the PL 
and BR groups. 
 
          
Values are mean ± SD. PL, Placebo group; BR, Nitrate group; Pre, pre-donation; Post, post-
donation ; HR, heart rate; [NO2
-
], nitrite concentration; [NO3
-
], nitrate concentration; [Hb], 
hemoglobin concentration; Hct, hematocrit. 
*
Significantly different from pre in the same 
condition (P<0.05). 
$
Significantly different from post supplementation value in the PL group 
(P<0.05). 
 
 
PL 
 
BR 
 
Pre Post Pre Post 
Blood pressure (mmHg)   
        Systolic 119 ± 7 118 ± 9 115 ± 11 113 ± 11
*
 
     Diastolic 69 ± 7 67 ± 7 64 ± 7 63 ± 7 
     Mean Arterial 86 ± 6 84 ± 8 81 ± 7 80 ± 7 
     Resting HR (b
.
min
-1
) 62 ± 9 66 ± 9 66 ± 11 71 ± 10
*
 
     
     Plasma [NO3
-
] (µM) 45 ± 11 50 ± 14
*
 47 ± 17 845 ± 350
*$
 
Plasma [NO2
-
] (nM) 73 ± 18 72 ± 21 81 ± 29 619 ± 363
*$
 
     
[Hb] (g
.
L
-1
) 149 ± 12 132 ± 18
*
 148 ± 15 137 ± 19
*
 
     Hct (%) 45 ± 2 41 ± 4
*
 45 ± 3 42 ± 5
*
 
. 
. 
. 
Table 2: Ventilatory and gas exchange dynamics, and blood lactate and glucose 
concentrations during moderate-intensity exercise prior to and following blood donation in 
the PL and BR groups 
 PL 
 
BR 
 Pre Post Pre Post 
 
    VO2 (L
.
min
-1
)     
Baseline  1.01 ± 0.17 0.97 ± 0.20 0.96 ± 0.20 0.87 ± 0.21
#
 
End exercise  1.72 ± 0.50 1.69 ± 0.53 1.65 ± 0.32 1.59 ± 0.34
#
 
 
    VCO2 (L
.
min
-1
) 
    Baseline 0.88 ± 0.19 0.86 ± 0.19 0.89 ± 0.19 0.81 ± 0.19
#
 
End exercise 1.60 ± 0.52 1.56 ± 0.50 1.53 ± 0.29 1.54 ± 0.29 
     RER 
    Baseline 0.88 ± 0.08 0.90 ± 0.06 0.89 ± 0.05 0.92 ± 0.09 
End exercise 0.94 ± 0.06 0.93 ± 0.06 0.93 ± 0.04 0.96 ± 0.06
#
 
 
    VE (L
.
min
-1
) 
    Baseline 25 ± 5 24 ± 5 24 ± 5 22 ± 5
#
 
End exercise 42  ± 11 40 ± 11 38 ± 6 38 ± 6 
     ∆ Blood [lactate] (mM) 0.0 ± 0.3 0.1 ± 0.4 0.1 ± 0.3 0.1 ± 0.4 
     ∆Blood [glucose] (mM) 0.1 ± 0.7 - 0.2 ± 0.7 0.00 ± 0.3 0.1 ± 0.5 
                  
Values are mean ± SD. PL, Placebo group; BR, Nitrate group; Pre, pre-donation; Post, post-
donation; [Bla], blood lactate concentration; [glu], blood glucose concentration; HR, heart 
rate. 
#
Significantly different from pre in the same condition (P<0.05). 
 
 
Table 3: Physiological responses to ramp incremental exercise prior to and following blood 
donation in the PL and BR groups.  
 
PL 
 
BR 
 
 
Pre Post Pre Post 
     
V̇O2peak (L
.
min
-1
) 3.84 ± 0.91 3.65 ± 0.85
*
 3.52 ± 0.65 3.40 ± 0.73 
     
V̇O2peak (mL
.
kg
-1.
min
-1
) 49.9 ± 11.0 47.4 ± 10.0
*
 46.6 ± 6.0 44.9 ± 6.0 
     Peak power (W) 341 ± 70 324 ± 69
*
 331 ± 68 322 ± 66
*
 
     GET (L
.
min
-1
) 1.76 ± 0.40 1.68 ± 0.43 1.64 ± 0.44 1.63 ± 0.44 
     GET (W) 117 ± 29 109 ± 27 116 ± 35 112 ± 24 
     V̇CO2peak (L
.
min
-1
) 4.69 ± 1.12 4.44 ± 0.97
*
 4.26 ± 0.68 4.36 ± 0.77 
     RER peak 1.22 ± 0.06 1.22 ± 0.05 1.22 ± 0.06 1.29 ± 0.06
*
 
     V̇Epeak (L.min-1) 156 ± 44 150 ± 43
*
 134 ± 28 137 ± 32 
     HRpeak (b
.
min
-1
) 177 ± 16 181 ± 9 178 ± 12 179 ± 10 
     ∆ Blood [lactate] (mM) 6.1 ± 1.4 5.5 ± 1.2 6.1 ± 1.9 6.8 ± 2.5 
     ∆ Blood [glucose] (mM) -0.2 ± 0.7 0.0 ± 1.1 -0.2 ± 0.4 0.0 ± 1.1 
     
Values are mean ± SD. PL, Placebo group; BR, Nitrate group; Pre, pre-donation; Post, post-
donation; GET, Gas exchange threshold; [Bla], blood lactate concentration; [glu], blood 
glucose concentration; HR, heart rate. 
*
Significantly different from pre in the same condition 
(P<0.05).  
 
 
 
 
 
Table 4: Near-infrared spectroscopy-derived [HHb] and TOI dynamics during moderate-
intensity and ramp incremental exercise prior to and following blood donation in the PL and 
BR groups. 
 
 
PL BR 
 
Pre Post Pre Post 
 
 
Moderate-intensity exercise 
[HHb] 
    
Baseline (AU) -4.4 ± 3.0 -2.3 ± 3.1 -3.1 ± 3.7 -1.9 ± 2.5 
60 s (AU) -1.2 ± 2.3 2.3 ± 5.0 -0.1 ± 5.0 0.6 ± 3.9 
120 s (AU) -0.9 ± 3.0 3.5 ± 6.2 -0.1 ± 4.9 1.0 ± 3.7 
240 s (AU) -0.7 ± 3.9 2.3 ± 5.2 0.1 ± 4.9 1.1 ± 3.6 
End (AU) 0.0 ± 4.4 2.5 ± 4.9 0.0 ± 4.9 1.0 ± 3.4 
 
    
TOI 
    Baseline (%) 65.3 ± 3.4 63.4 ± 3.3* 68.2 ± 4.3 70.1 ± 5.8 
60 s (%) 61.9 ± 4.9 57.7 ± 5.0* 64.6 ± 6.5 65.6 ± 8.5 
120 s (%) 61.9 ± 4.8 57.1 ± 5.7* 64.8 ± 6.1 65.6 ± 8.8 
240 s (%) 60.7 ± 6.6 58.1 ± 4.8* 64.8 ± 6.5 65.8 ± 8.9 
End (%) 61.4 ± 6.4 57.8 ± 5.0 65.3 ± 6.3 65.8 ± 8.9 
     
 
Ramp incremental exercise 
[HHb] 
    Baseline (AU) -6.2 ± 4.1 -3.4 ± 3.6 -5.1 ± 4.1 -2.6 ± 2.5 
120 s (AU) -3.3 ± 5.4 -0.1 ± 5.0 -2.7 ± 5.0 -0.7 ± 3.3 
240 s (AU) -0.8 ± 6.2 3.3 ± 5.8* -0.6 ± 5.8 1.4 ± 4.4 
360 s (AU) 2.0 ± 9.4 7.3 ± 9.1* 1.5 ± 6.6 3.4 ± 5.8 
End (AU) 6.2 ± 11.3 12.8 ± 10.1* 3.8 ± 7.6 5.3 ± 7.2 
     TOI 
    Baseline (%) 66.5 ± 3.9 67.3 ± 7.1 71.5 ± 3.9 72.5 ± 4.7 
120 s (%) 63.3 ± 5.1 64.6 ± 8.6 68.6 ± 5.5 69.5 ± 6.9 
240 s (%) 60.8 ± 6.5 60.7 ± 9.2 65.8 ± 7.5 65.9 ± 9.7 
360 s (%) 57.3 ± 11.5 55.4 ± 12.3 61.9 ± 8.6 61.7 ± 11.4 
End (%) 49.5 ± 12.6 47.6 ± 14.9 57.1 ± 7.0 57.2 ± 10.9 
 
Values are mean ± SD. PL, Placebo group; BR, Nitrate group; Pre, pre-donation; Post, post-
donation; [HHb], deoxygenated haemoglobin concentration; TOI, tissue oxygenation index; 
AU, arbitrary units. 
*
Significantly different from pre in the same condition (P<0.05).  
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